SEC Form 4 · accession 0000899243-17-029052
Whitehawk Therapeutics, Inc. · WHWK
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael W Rogers
Officer — Chief Financial Officer
Period of report
Dec 14, 2017
Accepted (ET)
Dec 18, 2017 · 5:06 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001422142
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $5.50 | Dec 14, 2017 | A | 293,006 | A | — | Nov 15, 2027 | Common Stock | 293,006 | 0 | D |
Explanation of responses
- F1Options exercisable as to 1/4th on the first anniversary of the vesting start date and an additional 1/48th monthly thereafter until the fourth anniversary of the vesting start date